<DOC>
	<DOCNO>NCT01619163</DOCNO>
	<brief_summary>Background : Osteoarthritis ( OA ) , common disable condition , commonest type arthritis worldwide . Knee OA 4th lead cause disability woman . Pain leading symptom often chronic nature lead significant morbidity decrease quality life . Synovitis prevalent knee OA treatment relieve synovitis may reduce pain . Objectives : A randomized double-blind placebo-controlled trial conduct assess whether 6 week daily low dose oral prednisolone improve pain , mobility systemic low-grade inflammation , short term determine sustain long term 12 week old adult moderate severe knee OA . Methods : 125 community-dwelling old adult age 65 year primary knee OA diagnose accord ACR criterion diagnosis primary OA knee berandomized 1:1 . Sixty three receive 7.5 mg/day prednisolone 62 receive placebo together usual therapy 6 week . The primary outcome measure pain reduction . Secondary outcome measure reduction systemic inflammation improvement physical functioning score . Alterations dosage analgesic/NSAID drug use record . Safety tolerability also assess . Data collect baseline , 6 week 12 week determine change result obtain 6 week . Exclusion criterion include inflammatory serious medical condition . Knee OA document radiographic examination use Kellgren-Lawrence scale . Symptomatic OA define need take NSAIDs daily LequesneAlgofunctional Index ( LFI ) score &gt; 4 . Clinical assessment include : Visual Analogue Pain Scale ( VAS , 0-100 ) , self-reported physical function measure Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) , WOMAC pain stiffness score , six-minute walk distance ( 6MWD ) . All patient undergo physical examination question number flare , pain analgesic use . Blood sample collect serum level IL-1 , IL-6 , TNF-alpha hsCRP measure patient .</brief_summary>
	<brief_title>Prednisolone Pain Reduction Knee OA</brief_title>
	<detailed_description />
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Communitydwelling old adult age 65 year primary knee OA diagnose accord ACR criterion diagnosis primary OA knee Any inflammatory serious medical condition</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Prednisolone ,</keyword>
	<keyword>pain ,</keyword>
	<keyword>inflammation ,</keyword>
	<keyword>mobility</keyword>
	<keyword>Function</keyword>
</DOC>